By Chen Jing

Basilea Pharmaceutica China Ltd. is located in Haimen economic and technological development zone. It is a wholly owned subsidiary of Basilea Pharmaceutica Ltd. (Basilea) in Switzerland. BPC has 3000m2 of chemistry lab space and 800m2 of analytical lab space. Based on experienced high quality professionals and first class research and development facilities, it participated in research and development of all bacterial infection, fungus infection and anti-cancer innovative drugs from the headquarters, and became an essential part of new drug research and development of the headquarters.

Talking about the company’s growth and development, the person in charge Zhou You said that Haimen government established green channel to help in the company’s settlement, such as company registration and land purchase, it usually takes half a year, but with the support of Haimen government, everything was completed in only one to two months.

In the present, the company’s research and development center has about 60 researchers whose average age is 36. Among them, more than 70% have master degrees. Influx of talents created power and energy like running water for the company’s development. Although research and development of innovative medicine is a time consuming, costly and risky progress, the target ‘provide better innovative medicine for severe patients’ has not been changed. The bacterial infection and fungus infection innovative drugs whose research and development were participated by the Chinese subsidiary participated are sold in over 100 countries in the world.

Since Basilea Pharmaceutica settled in Haimen, the headquarters introduced the successful experiences in Nantong Haimen many times to attract more Swiss pharmaceutical companies to settle in Nantong.